Article info

Download PDFPDF

DGI-062 Sorafenib, Sunitinib and Everolimus in Metastatic Renal Cell Carcinoma: Efficacy and Safety
Free

Authors

Citation

Ormazabal Goicoechea I, Polanco Paz M, Sanmartin Fenollera P, et al
DGI-062 Sorafenib, Sunitinib and Everolimus in Metastatic Renal Cell Carcinoma: Efficacy and Safety

Publication history

  • First published March 12, 2013.
Online issue publication 
March 12, 2013

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.